Is Wall Street Bullish or Bearish on Quest Diagnostics Stock?

With a market cap of $18.9 billion, Quest Diagnostics Incorporated (DGX) is a leading provider of diagnostic testing services in the United States and internationally. The company delivers a wide range of routine and advanced diagnostic information services through its brands and network of laboratories, serving healthcare providers, insurers, employers, and government institutions.

Shares of the Secaucus, New Jersey.-based company have outperformed the broader market over the past 52 weeks. DGX has returned 19.6% over this time frame, while the broader S&P 500 Index ($SPX) has gained 10.1%. Moreover, Quest Diagnostics stock has soared 12.4% on a YTD basis, compared to SPX's marginal decline.